“ Agilent is accelerating lab transformation in India through platforms like CrossLab Connect, which enables cloud-based lab operations, and OpenLab software, which ensures data integrity and regulatory compliance.”
INTERVIEW
traceability, and simplify audits.
This digital-first approach is helping Indian labs maximize uptime and operational efficiency while aligning with global best practices.
How has Agilent’ s business in India evolved over the past few years, and what are the key drivers of this growth? What proportion of Agilent’ s global revenues does India currently contribute, and how do you see this evolving?
India has emerged as a strategic growth market for Agilent, driven by rising investments in pharmaceuticals, diagnostics, and environmental monitoring. The inauguration of the India Solution Center in Manesar underscores Agilent’ s commitment to local innovation and customercentric solutions. While Agilent does not publicly disclose country-specific revenue contributions, the company reported $ 6.51 billion in global revenue for FY2024. With India’ s expanding life sciences and healthcare sectors, Agilent anticipates continued doubledigit growth in the region.
How is Agilent helping confirm the identity of GLP-1 drugs quickly to accelerate batch approvals?
Agilent supports the rapid and reliable characterisation of GLP-1 analogs through comprehensive, end-to-end workflow solutions that span from sample preparation to final data reporting. These workflows are designed to meet global regulatory expectations while improving speed, consistency, and data integrity.
A key strength lies in Agilent’ s ability to integrate automated sample preparation, advanced analytical technologies, and intelligent software platforms. This includes solutions for automated peptide sample prep, which enhances reproducibility and reduces manual errors; high-resolution analysis for confirming molecular identity and detecting impurities; flexible chromatographic methods tailored for complex peptide formulations; and structural confirmation tools for identifying sequence variants and modifications.
“ Agilent is accelerating lab transformation in India through platforms like CrossLab Connect, which enables cloud-based lab operations, and OpenLab software, which ensures data integrity and regulatory compliance.”
A key differentiator is Agilent’ s
26
BioVoiceNews | July-August 2025